Gregori Casals
Featured publications
-
Mesoporous silica coated CeO2 nanozymes with combined lipid-lowering and antioxidant activity induce long-term improvement of the metabolic profile in obese Zucker rats
Authors:Reference: Nanoscale 2021. -
Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma
Authors:Reference: Hepatology 2020. -
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Authors:Reference: Nature Medicine 2018. -
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide.
Authors:Reference: Frontiers In Immunology 2017. -
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display antiinflammatory properties in rats with liver fibrosis
Authors:Reference: Journal Of Hepatology 2016. -
Microwave-assisted derivatization: Application to steroid profiling by gas chromatography/mass spectrometry
Authors:Reference: Journal Of Chromatography B-Analytical Technologies In The Biomedical And Life Sciences 2014. -
Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes
Authors:Reference: American Journal Of Physiology-Heart And Circulatory Physiology 2009.
Featured Projects
-
Evaluation of antioxidant and anti-inflammatory properties of cerium oxide nanoparticles as novel therapeutic strategy in hepatic steatosis.
Principal investigator: Gregori Casals MercadalFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación SanitariaDuration: 01/01/2016 - 01/01/2018 -
Cerium oxide nanoparticles as a new therapeutic tool for tissue regeneration in liver diseases
Principal investigator: Víctor Franco PuntesFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fundació La Marató de TV3Duration: 01/01/2013 - 01/01/2015 -
Basic and translational implications of the functional and molecular alterations of the hepatic endothelium in cirrhosis
Principal investigator: Manuel Morales RuizFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento)Duration: 01/01/2011 - 01/01/2013 -
Pathophysiological role of activated liver endothelial cells in cirrhosis. Possible therapeutical implications
Principal investigator: Manuel Morales RuizFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Dirección General de Investigación Científica (Ministerio de Educación y Ciencia)Duration: 01/01/2008 - 01/01/2010 -
Aplicaciones de la genómica en la identificación de dianas terapéuticas específicas para el endotelio hepático en la cirrosis, función fisiopatológica de VEGF.
Principal investigator: Manuel Morales RuizFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación SanitariaDuration: 01/01/2005 - 01/01/2007